Cargando…
Human Vaccines: News
High safety marks for Merck’s Gardasil Cuba tests prostate cancer vaccine HIV’s weak spot: V2 Unique anti-cancer agent ColoAd1 enters the clinic Broadly neutralizing antibodies against influenza A and B discovered Clinical trials initiated: Nexvax2 therapeutic vaccine for celiac disease The 20 top-s...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601129/ https://www.ncbi.nlm.nih.gov/pubmed/23151443 http://dx.doi.org/10.4161/hv.22753 |
| _version_ | 1782475724185141248 |
|---|---|
| author | Riedmann, Eva M. |
| author_facet | Riedmann, Eva M. |
| author_sort | Riedmann, Eva M. |
| collection | PubMed |
| description | High safety marks for Merck’s Gardasil Cuba tests prostate cancer vaccine HIV’s weak spot: V2 Unique anti-cancer agent ColoAd1 enters the clinic Broadly neutralizing antibodies against influenza A and B discovered Clinical trials initiated: Nexvax2 therapeutic vaccine for celiac disease The 20 top-selling vaccines in the first half of 2012 Influenza vaccine safe for pregnant women |
| format | Online Article Text |
| id | pubmed-3601129 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36011292013-03-22 Human Vaccines: News Riedmann, Eva M. Hum Vaccin Immunother News, Policy and Profiles High safety marks for Merck’s Gardasil Cuba tests prostate cancer vaccine HIV’s weak spot: V2 Unique anti-cancer agent ColoAd1 enters the clinic Broadly neutralizing antibodies against influenza A and B discovered Clinical trials initiated: Nexvax2 therapeutic vaccine for celiac disease The 20 top-selling vaccines in the first half of 2012 Influenza vaccine safe for pregnant women Landes Bioscience 2012-11-01 /pmc/articles/PMC3601129/ /pubmed/23151443 http://dx.doi.org/10.4161/hv.22753 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | News, Policy and Profiles Riedmann, Eva M. Human Vaccines: News |
| title | Human Vaccines: News |
| title_full | Human Vaccines: News |
| title_fullStr | Human Vaccines: News |
| title_full_unstemmed | Human Vaccines: News |
| title_short | Human Vaccines: News |
| title_sort | human vaccines: news |
| topic | News, Policy and Profiles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601129/ https://www.ncbi.nlm.nih.gov/pubmed/23151443 http://dx.doi.org/10.4161/hv.22753 |
| work_keys_str_mv | AT riedmannevam humanvaccinesnews |